PLATINUM INVESTMENT MANAGEMENT LTD
Position in ROIV — Roivant Sciences Ltd.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,269,929
+$710,533 QoQ
Shares Held
92,397
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#172
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. ROIV ranks #11 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $7,740,017 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
154,220 | $5,968,314 | |
| 3 | IMVT |
Immunovant, Inc.
|
144,671 | $5,574,173 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $5,277,935 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
138,708 | $5,169,647 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,878,309 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
90,363 | $4,849,782 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
134,217 | $4,137,910 |
All Filings in ROIV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,269,929 | 92,397 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,559,396 | 92,397 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,104,468 | 189,146 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,622,424 | 239,420 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,424,645 | 481,335 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $5,002,591 | 495,797 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,246,606 | 528,031 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,093,477 | 528,031 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,022,204 | 569,745 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,051,755 | 669,047 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,513,397 | 669,047 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,993,189 | 598,732 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $7,646,436 | 758,575 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,594,625 | 622,578 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,439,355 | 555,614 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,627,957 | 505,577 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,057,698 | 505,577 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,598,796 | 323,643 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,262,321 | 323,643 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||